Canterbury Scientific Limited

Pharmaceuticals, Biotechnology and Life Sciences

Targets set1.5°C

SBTI ID

40026908

Informations générales

Localisation

New Zealand

Oceania

Secteur d'activité

Pharmaceuticals, Biotechnology and Life Sciences

Type d'organisation

SME

Dernière mise à jour

27/11/2025

Objectifs à court terme (Near-Term)
Engagement de réduction des émissions à horizon 2034

Statut

Targets set

Classification

1.5°C

Année cible

2034

Progression vers l'objectif58%
2015 (année de référence)2034
Description complète des objectifs

This target was approved using a streamlined target validation route exclusive to small and medium-sized enterprises (SMEs). https://docs.sbtiservices.com/resources/FAQsforSMEs.pdf Canterbury Scientific Limited commits to reduce absolute scope 1 emissions 58.8% by 2034 from a 2024 base year. Canterbury Scientific Limited also commits to maintain zero scope 2 emissions through 2034, and to measure and reduce its scope 3 emissions from a 2024 base year.

Classification détaillée

The targets covering greenhouse gas emissions from company operations (scopes 1 and 2) are consistent with reductions required to keep warming to 1.5°C

Source : Science Based Targets initiative | Données publiques